Does off-pump revascularization reduce coronary endothelial dysfunction?

Journal of Cardiac Surgery

Volumn 19, Issue 5, 2004, Pages 440-443

  Lazar, Harold L ^a,b   Bao, Yusheng ^a   Rivers, Samuel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DYSKINESIA; HEART INFARCTION; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUNG EDEMA; NONHUMAN; OFF PUMP CORONARY SURGERY; SWINE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; CARDIOPULMONARY BYPASS; COMPLEMENT INACTIVATOR PROTEINS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS, OFF-PUMP; ENDOTHELIUM, VASCULAR; MODELS, ANIMAL; RECEPTORS, COMPLEMENT; SWINE;

EID: 4644238641     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0886-0440.2004.00315.x     Document Type: Conference Paper

References (13)

1. Hennein HA, Ebba H, Rodriguez JL: Relationship of the pro-inflammatory cytokines to myocardium ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994;108:626-635.
2. Seeger W, Suttrop N, Hellwig A, et al: Non-lytic terminal complement complexes may serve as calcium gates to elicit leukotriene by generations in human polymorphonuclear leukocytes. J Immunol 1986;150:1286-1294.
3. Lazar HL, Bao Y, Gaudiani J, et al: Total complement inhibition: An effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass. Circulation 1994;100:1438-1442.
4. Lazar HL, Hamasaki T, Bao Y, et al: Soluble complement receptor type 1 limits damage during revascularization of ischemic myocardium. Ann Thorac Surg 1998;65:973-977.
5. Ascione R, Lloyd CT, Underwood MJ, et al: Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000;69:1198-1204.
6. Wan S, Izzat MB, Lee TW, et al: Avoiding cardiopulmonary bypass in multi-vessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 1999;68:52-57.
7. Lazar HL, Yang XM, Rivers S, et al: Role of percutaneous bypass in reducing infarct size after revascularization for acute coronary insufficiency. Circulation 1991;84:416-421.
8. Lazar HL, Bao Y, Rivers S, et al: High tissue affinity ACE inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg 2001;72:548-554.
9. Mulligan MS, Polley MJ, Brayer RJ, et al: Neutrophil-dependent acute lung injury: Requirement for P-selectin (6 MP-140). J Clin Invest 1992;90:1600-1607.
10. Lazar HL, Bao Y, Rivers S, et al: Pretreatment with angiotension- converting inhibitors attenuates ischemic reperfusion injury during coronary revascularization. Ann Thorac Surg 2002;73:1522-1527.
11. Lockowandt, U, Liska J, Franco-Cereceda A: Short ischemia causes endothelial dysfunction in porcine coronary vessels in an in vivo model. Ann Thorac Surg 2001;71:265-269.
12. Hangler HS, Pfaller K, Antretter H, et al: Coronary endothelial injury after local occlusion on the human beating heart. Ann Thorac Surg 2001;71:122-127.
13. Perrault LP, Menasche P, Wasse FM, et al: Endothelial effects of hemostatic devices for continuous cardioplegia on minimally invasive surgery. Ann Thorac Surg 1996;62:1158-1163.